Literature DB >> 7929142

Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

M E Olah1, K A Jacobson, G L Stiles.   

Abstract

Adenosine receptor (AR) agonists and antagonists are approximately 100-fold and 100,000-fold, respectively, more potent at the bovine A1AR as compared to the rat A3AR. To determine regions of ARs involved in ligand recognition, chimeric receptors composed of bovine A1AR and rat A3AR sequence were constructed and their ligand binding properties examined following expression in COS-7 cells. Substitutions of the second extracellular loop or a region encompassing transmembrane domains 6 and 7 of the A1AR into the A3AR resulted in enhanced affinities of both agonists and antagonists compared to wild-type A3AR. The region of the second extracellular loop of the A1AR responsible for this effect was identified as the distal eleven amino acids of the loop. Replacement of this segment of the A3AR with that of the A1AR in combination with the regions encompassing transmembrane domains 6 and 7 resulted in a 50,000-fold increase in the Kd for antagonist radioligand, [3H]1,3-dipropyl-8- cyclopentylxanthine. Agonist affinity at this chimeric was over 100-fold greater than that displayed by wild-type A3AR. Thus, multiple regions of ARs including a segment of the second extracellular loop are involved in ligand recognition, and considerable overlap exists in structural features required for agonist and antagonist binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929142      PMCID: PMC3437327     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Cardiovascular purinoceptors.

Authors:  R A Olsson; J D Pearson
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

2.  Demonstration of distinct agonist and antagonist conformations of the A1 adenosine receptor.

Authors:  W W Barrington; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

3.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.

Authors:  R R Huang; H Yu; C D Strader; T M Fong
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

5.  Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

Authors:  A De Lean; A A Hancock; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Authors:  M E Olah; C Gallo-Rodriguez; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

8.  Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.

Authors:  K N Klotz; M J Lohse; U Schwabe
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

9.  Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.

Authors:  M S Choudhary; S Craigo; B L Roth
Journal:  Mol Pharmacol       Date:  1992-10       Impact factor: 4.436

10.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

View more
  29 in total

Review 1.  Structural organization of G-protein-coupled receptors.

Authors:  A L Lomize; I D Pogozheva; H I Mosberg
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

Review 2.  New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi
Journal:  Mol Pharmacol       Date:  2012-06-13       Impact factor: 4.436

3.  Nucleoside modification and concerted mutagenesis of the human A3 adenosine receptor to probe interactions between the 2-position of adenosine analogs and Gln167 in the second extracellular loop.

Authors:  Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2005       Impact factor: 1.381

4.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

5.  Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.

Authors:  H Bourdon; S Trumpp-Kallmeyer; H Schreuder; J Hoflack; M Hibert; C G Wermuth
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

Review 6.  What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?

Authors:  Mayako Michino; Thijs Beuming; Prashant Donthamsetti; Amy Hauck Newman; Jonathan A Javitch; Lei Shi
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.

Authors:  Robert R Luedtke; Yogesh Mishra; Qi Wang; Suzy A Griffin; Cathy Bell-Horner; Michelle Taylor; Suwanna Vangveravong; Glenn H Dillon; Ren-Qi Huang; David E Reichert; Robert H Mach
Journal:  ACS Chem Neurosci       Date:  2012-10-12       Impact factor: 4.418

8.  Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.

Authors:  Hendrik Preuss; Prasanta Ghorai; Anja Kraus; Stefan Dove; Armin Buschauer; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

9.  Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints.

Authors:  Viktor Hornak; Shivani Ahuja; Markus Eilers; Joseph A Goncalves; Mordechai Sheves; Philip J Reeves; Steven O Smith
Journal:  J Mol Biol       Date:  2009-12-11       Impact factor: 5.469

10.  Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation.

Authors:  Shivani Ahuja; Viktor Hornak; Elsa C Y Yan; Natalie Syrett; Joseph A Goncalves; Amiram Hirshfeld; Martine Ziliox; Thomas P Sakmar; Mordechai Sheves; Philip J Reeves; Steven O Smith; Markus Eilers
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.